Kairos Pharma, LTD. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Kairos Pharma, LTD. on October 10, 2024, covering events reported on October 9, 2024. The Company is a Delaware corporation listed on The Nasdaq Stock Market LLC under the symbol "KAPA" and is classified as an emerging growth company.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate communications rather than financial performance data.
Material Changes
There are no material changes to financial conditions or operations reported in this filing. The primary event is the announcement of the Chief Executive Officer's participation in an upcoming investor conference.
Guidance, Outlook, and Management Commentary
- Upcoming Event: CEO Dr. John S. Yu, M.D., is scheduled to participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit, held virtually from October 15 to 17, 2024.
- Investor Presentation: On October 10, 2024, the Company updated its corporate presentation ("Investor Deck") for the summit and posted it on its website. A copy is attached as Exhibit 99.1.
- Forward-Looking Statements: The filing contains forward-looking statements regarding future results, strategy, and plans. These are subject to risks and uncertainties that may cause actual results to differ materially.
- Legal Disclaimer: Information in Item 8.01 and Exhibit 99.1 is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings.
Key Facts for Investor Verification
- Verify the content of the updated "Investor Deck" (Exhibit 99.1) posted on the Company's website for the latest strategic updates.
- Confirm the schedule and access details for the 2024 Maxim Healthcare Virtual Summit (October 15-17, 2024).
- Review the Company's Form S-1 and periodic reports for detailed risk factors and historical financial data, as this 8-K does not contain financial statements.